M&T Bank
AVEO

M&T Bank’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

M&T Bank’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,000
Closed -$146K – 1647
2021
Q1 		$146K Hold
20,000
– – ﹤0.01% 1450
2020
Q4 		$115K Buy
+20,000
New +$115K ﹤0.01% 1574

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

M&T Bank's AVEO Position: Q2 2021 in Review

M&T Bank sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2021, closing a stake of 20,000 shares — an estimated $146K sold.

M&T Bank first reported a position in AVEO in Q4 2020 and held it in 2 quarters. The position peaked at $146K in Q1 2021. 63 funds tracked by Wall St. Rank hold AVEO as of Q2 2021.

  • M&T Bank reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • M&T Bank sold 20,000 AVEO Pharmaceuticals, Inc. shares in Q2 2021, an estimated $146K.
  • M&T Bank first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2020 and held it in 2 quarters.
  • M&T Bank's AVEO Pharmaceuticals, Inc. position peaked at $146K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2021.

Based on M&T Bank's 13F filing for Q2 2021, filed 13 Aug 2021.